long intergenic non-protein coding RNA 1284Genealiases: []
Q-omics provides the consensus-scored LINC01284 profile across patient tissues and cancer cell-line models. LINC01284 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in COAD. Among the 18 cancer types available for tumor–normal comparison, LINC01284 is differentially expressed in 7, with the highest sampling consensus in KICH. Additionally, LINC01284 RNA expression shows 9,239 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight COAD, KICH, and THYM as cancer lineages where LINC01284 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01284 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01284 survival associations across molecular data types. LINC01284 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01284 RNA expression–survival associations across cancer types. High LINC01284 expression shows unfavorable associations in COAD, LUSC and KICH, but favorable associations in PAAD, CESC and KIRP. The COAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify COAD as the clearest survival context for LINC01284 RNA expression.
This table summarizes LINC01284 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01284. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01284 shows lower tumor expression in KICH, LUAD, LUSC, BRCA, KIRC and COAD. The KICH box plot shows higher LINC01284 RNA expression in normal versus tumor tissue (log2 FC = −0.154, t-test p = .001).
This table shows molecular features associated with LINC01284 in patient tissues and cancer cell lines. In patient samples, LINC01284 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
